Oncogene swap as a novel mechanism of acquired resistance to epidermal growth factor receptor‐tyrosine kinase inhibitor in lung cancer

Mutant selective epidermal growth factor receptor‐tyrosine kinase inhibitors (EGFR‐TKIs), such as rociletinib and AZD9291, are effective for tumors with T790M secondary mutation that become refractory to first‐generation EGFR‐TKI. However, acquired resistance to these prospective drugs is anticipate...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Cancer Sci
Main Authors: Mizuuchi, Hiroshi, Suda, Kenichi, Murakami, Isao, Sakai, Kazuko, Sato, Katsuaki, Kobayashi, Yoshihisa, Shimoji, Masaki, Chiba, Masato, Sesumi, Yuichi, Tomizawa, Kenji, Takemoto, Toshiki, Sekido, Yoshitaka, Nishio, Kazuto, Mitsudomi, Tetsuya
פורמט: Artigo
שפה:Inglês
יצא לאור: John Wiley and Sons Inc. 2016
נושאים:
Original Articles
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4832847/
https://ncbi.nlm.nih.gov/pubmed/26845230
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12905
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים